We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+15.2%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.07B
AUM Growth
+$251M
Cap. Flow
-$68.7M
Cap. Flow %
-3.32%
Top 10 Hldgs %
44.01%
Holding
2,647
New
722
Increased
455
Reduced
467
Closed
877

Top Buys

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$17.2M
2
SPR
Spirit AeroSystems
SPR
+$15.4M
3
BABA icon
Alibaba
BABA
+$12.1M
4
NFLX icon
Netflix
NFLX
+$11.9M
5
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
+$8.12M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$9.18M
2
EE
El Paso Electric Company
EE
+$8.45M
3
IBKC
IBERIABANK Corp
IBKC
+$7.95M
4
CZR
Caesars Entertainment Corporation
CZR
+$7.02M
5
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
+$6.27M

Sector Composition

Rank Sector Weight
1 Technology 6.57%
2 Consumer Discretionary 4.71%
3 Industrials 3.64%
4 Healthcare 3.58%
5 Communication Services 3.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEB icon
1626
Seaboard Corp
SEB
$4.08B
$3K ﹤0.01%
1
-1
-50% -$2.84K
SNOW icon
1627
Snowflake
SNOW
$117B
$3K ﹤0.01%
+10
New +$2.38K
SPRO icon
1628
Spero Therapeutics
SPRO
$71.8M
$3K ﹤0.01%
300
+200
+200% +$2.37K
SYRE icon
1629
Spyre Therapeutics
SYRE
$8.98B
$3K ﹤0.01%
+16
New +$2.96K
TISI icon
1630
Team
TISI
$101M
$3K ﹤0.01%
62
– –
TTEC icon
1631
TTEC Holdings
TTEC
$77.4M
$3K ﹤0.01%
+50
New +$2.63K
TBRG
1632
DELISTED
TruBridge
TBRG
$3K ﹤0.01%
+100
New +$2.64K
ITCI
1633
PUT
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3K ﹤0.01%
100
-300
-75% -$6.84K
CDMO
1634
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$3K ﹤0.01%
+400
New +$3.03K
SAVE
1635
DELISTED
Spirit Airlines, Inc.
SAVE
$3K ﹤0.01%
200
– –
VRTV
1636
DELISTED
VERITIV CORPORATION
VRTV
$3K ﹤0.01%
+200
New +$3.21K
ALBO
1637
PUT
DELISTED
Albireo Pharma Inc
ALBO
$3K ﹤0.01%
+100
New +$2.91K
BNFT
1638
DELISTED
Benefitfocus, Inc.
BNFT
$3K ﹤0.01%
+300
New +$3.29K
TCDA
1639
DELISTED
Tricida, Inc. Common Stock
TCDA
$3K ﹤0.01%
+300
New +$4.38K
SPNE
1640
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$3K ﹤0.01%
+200
New +$2.42K
EXTN
1641
DELISTED
Exterran Corporation
EXTN
$3K ﹤0.01%
830
-114,283
-99% -$571K
BXRX
1642
CALL
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$3K ﹤0.01%
+1
New +$4.53K
AVEO
1643
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$3K ﹤0.01%
+500
New +$2.47K
CKH
1644
DELISTED
Seacor Holdings Inc.
CKH
$3K ﹤0.01%
+100
New +$2.97K
AGYS icon
1645
Agilysys
AGYS
$3.25B
$2K ﹤0.01%
73
-600
-89% -$13.4K
AMC icon
1646
PUT
AMC Entertainment Holdings
AMC
$2.35B
$2K ﹤0.01%
+40
New +$2K
API
1647
Agora
API
$408M
$2K ﹤0.01%
+50
New +$2.33K
ATER icon
1648
Aterian
ATER
$5.26M
$2K ﹤0.01%
+17
New +$1.5K
ATKR icon
1649
Atkore
ATKR
$3.17B
$2K ﹤0.01%
+100
New +$2.71K
BHE icon
1650
Benchmark Electronics
BHE
$2.89B
$2K ﹤0.01%
123
-330
-73% -$6.71K
64 65
66
67 68

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
MRL
Mantle Ridge LP New York $1.33B AUM 11.36% 1-Year Est. Return
COCM
Charter Oak Capital Management Portsmouth, New Hampshire $1.29B AUM 13.93% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Prelude Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Prelude Capital Management held 2,647 positions worth $2.07B, up 14% from $1.82B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Prelude Capital Management withdrew a net $68.7M in Q3 2020, closing 877 positions and reducing 467 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $9.18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.6% of assets, down from 7% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Prelude Capital Management opened a new position in Equitrans Midstream Corporation Common Stock worth $14.9M.

  • Prelude Capital Management's largest Q3 2020 buy was Equitrans Midstream Corporation Common Stock: 1,760,179 shares worth $14.9M.
  • Prelude Capital Management added most to Alibaba in Q3 2020, an estimated $12.1M increase.
  • Prelude Capital Management's biggest Q3 2020 reduction was Broadcom, cutting an estimated $5.72M.
  • Prelude Capital Management fully exited Invesco QQQ Trust in Q3 2020, selling an estimated $9.18M.
  • Prelude Capital Management's ten largest holdings make up 44% of its $2.07B portfolio in Q3 2020.
  • Prelude Capital Management opened 722 new positions and closed 877 in Q3 2020.
  • Prelude Capital Management's portfolio value rose 14% quarter-over-quarter to $2.07B.

Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.